全文获取类型
收费全文 | 145566篇 |
免费 | 51285篇 |
国内免费 | 4873篇 |
专业分类
耳鼻咽喉 | 2049篇 |
儿科学 | 5418篇 |
妇产科学 | 1245篇 |
基础医学 | 21845篇 |
口腔科学 | 6452篇 |
临床医学 | 21116篇 |
内科学 | 31572篇 |
皮肤病学 | 8130篇 |
神经病学 | 16243篇 |
特种医学 | 5242篇 |
外国民族医学 | 27篇 |
外科学 | 20636篇 |
综合类 | 16013篇 |
现状与发展 | 13篇 |
一般理论 | 25篇 |
预防医学 | 10322篇 |
眼科学 | 3243篇 |
药学 | 13460篇 |
53篇 | |
中国医学 | 6740篇 |
肿瘤学 | 11880篇 |
出版年
2024年 | 250篇 |
2023年 | 1075篇 |
2022年 | 2572篇 |
2021年 | 4962篇 |
2020年 | 7813篇 |
2019年 | 12759篇 |
2018年 | 12178篇 |
2017年 | 13693篇 |
2016年 | 14020篇 |
2015年 | 14939篇 |
2014年 | 15767篇 |
2013年 | 16503篇 |
2012年 | 10355篇 |
2011年 | 10493篇 |
2010年 | 13754篇 |
2009年 | 9484篇 |
2008年 | 6771篇 |
2007年 | 5486篇 |
2006年 | 5281篇 |
2005年 | 4298篇 |
2004年 | 3638篇 |
2003年 | 3372篇 |
2002年 | 2909篇 |
2001年 | 2505篇 |
2000年 | 1991篇 |
1999年 | 1215篇 |
1998年 | 546篇 |
1997年 | 588篇 |
1996年 | 428篇 |
1995年 | 358篇 |
1994年 | 336篇 |
1993年 | 218篇 |
1992年 | 186篇 |
1991年 | 166篇 |
1990年 | 150篇 |
1989年 | 113篇 |
1988年 | 103篇 |
1987年 | 89篇 |
1986年 | 75篇 |
1985年 | 51篇 |
1984年 | 37篇 |
1983年 | 38篇 |
1982年 | 16篇 |
1981年 | 18篇 |
1980年 | 10篇 |
1979年 | 14篇 |
1978年 | 12篇 |
1974年 | 15篇 |
1971年 | 17篇 |
1970年 | 8篇 |
排序方式: 共有10000条查询结果,搜索用时 616 毫秒
91.
92.
93.
94.
95.
Yi Li Ying Chen Xiang Li Jian Wu Jing-Ying Pan Ri-Xin Cai Ri-Yun Yang Xiao-Dong Wang 《中国神经再生研究》2019,(9)
In the search for a therapeutic schedule for spinal cord injury, it is necessary to understand key genes and their corresponding regulatory networks involved in the spinal cord injury process. However, ad hoc selection and analysis of one or two genes cannot fully reveal the complex molecular biological mechanisms of spinal cord injury. The emergence of second-generation sequencing technology(RNA sequencing) has provided a better method. In this study, RNA sequencing technology was used to analyze differentially expressed genes at different time points after spinal cord injury in rat models established by contusion of the eighth thoracic segment. The numbers of genes that changed significantly were 944, 1362 and 1421 at 1, 4 and 7 days after spinal cord injury respectively. After gene ontology analysis and temporal expression analysis of the differentially expressed genes, C5ar1, Socs3 and CCL6 genes were then selected and identified by real-time polymerase chain reaction and western blot assay. The mRNA expression trends of C5ar1, Socs3 and CCL6 genes were consistent with the RNA sequencing results. Further verification and analysis of C5ar1 indicate that the level of protein expression of C5ar1 was consistent with its nucleic acid level after spinal cord injury. C5ar1 was mainly expressed in neurons and astrocytes. Finally, the gene Itgb2,which may be related to C5ar1, was found by Chilibot database and literature search. Immunofluorescence histochemical results showed that the expression of Itgb2 was highly consistent with that of C5ar1. Itgb2 was expressed in astrocytes. RNA sequencing technology can screen differentially expressed genes at different time points after spinal cord injury. Through analysis and verification, genes strongly associated with spinal cord injury can be screened. This can provide experimental data for further determining the molecular mechanism of spinal cord injury, and also provide possible targets for the treatment of spinal cord injury. This study was approved ethically by the Laboratory Animal Ethics Committee of Jiangsu Province, China(approval No. 2018-0306-001) on March 6, 2018. 相似文献
96.
Tuberculosis (TB) remains one of a major health problem worldwide. Tuberculosis vaccine research has made an extraordinary progress over the past few years. However, there is still no replacement for the Bacillus Calmette‐Guérin vaccine, the only TB vaccine licensed for human use. Therefore, the discovery and development of new TB vaccines remains a priority. This article discusses current strategies used to diversify TB vaccines and includes discussion of the status of efforts to improve protection against Mycobacterium tuberculosis (M tb) infection or TB disease by developing new and safe TB vaccines. This article also highlights the current research efforts in immune‐enhancing approaches to improve vaccination efficacy. The development of more effective TB vaccines might have significant impact on global TB control. 相似文献
97.
Erika Cecon Anna Ivanova Marine Luka Florence Gbahou Anne Friederich Jean‐Luc Guillaume Patrick Keller Klaus Knoch Raise Ahmad Philippe Delagrange Michele Solimena Ralf Jockers 《Journal of pineal research》2019,66(2)
Melatonin receptors play important roles in the regulation of circadian and seasonal rhythms, sleep, retinal functions, the immune system, depression, and type 2 diabetes development. Melatonin receptors are approved drug targets for insomnia, non‐24‐hour sleep‐wake disorders, and major depressive disorders. In mammals, two melatonin receptors (MTRs) exist, MT1 and MT2, belonging to the G protein‐coupled receptor (GPCR) superfamily. Similar to most other GPCRs, reliable antibodies recognizing melatonin receptors proved to be difficult to obtain. Here, we describe the development of the first monoclonal antibodies (mABs) for mouse MT1 and MT2. Purified antibodies were extensively characterized for specific reactivity with mouse, rat, and human MT1 and MT2 by Western blot, immunoprecipitation, immunofluorescence, and proximity ligation assay. Several mABs were specific for either mouse MT1 or MT2. None of the mABs cross‐reacted with rat MTRs, and some were able to react with human MTRs. The specificity of the selected mABs was validated by immunofluorescence microscopy in three established locations (retina, suprachiasmatic nuclei, pituitary gland) for MTR expression in mice using MTR‐KO mice as control. MT2 expression was not detected in mouse insulinoma MIN6 cells or pancreatic beta‐cells. Collectively, we report the first monoclonal antibodies recognizing recombinant and native mouse melatonin receptors that will be valuable tools for future studies. 相似文献
98.
99.
100.